News

Trio to develop bio-based diapers
Enlarge image

BusinessDenmarkGermany

Trio to develop bio-based diapers

20.08.2012 - German chemicals company BASF, US-based Cargill and Danish biotech
Novozymes join forces to develop technologies to produce acrylic acid from
renewable feed stocks.

BASF SE, the world's largest producer of acrylic acid, will join the research collaboration with Novozymes A/S and Cargill Inc., which have already worked together on renewable acrylic technology since 2008. Both firms have been involved in the development of microorganisms that are capable of producing 3-hydroxypropionic acid (3-HP) from renewable feedstock. 3-HP is one potential chemical precursor for the synthesis of acrylic acid.

The bio-based acrylic acid will first be used to manufacture superabsorbent polymers, which can soak up large amounts of liquid and are used mainly in baby diapers and other hygiene products, but also in adhesive raw materials and coatings.

According to the three companies, the annual global market volume of acrylic acid was approximately 4.5 million tons with a value of around US-$11bn at the end of 2011, with a annual growth rate of about 4%.

http://www.european-biotechnology-news.com/news/news/2012-03/trio-to-develop-bio-based-diapers.html

FinancingPoland

24.03.2015 Poland has announced the closing of a new venture capital fund at US$42m (€32m). The fund, which is the first of its kind in Poland, is dedicated to the Life Sciences with a strong connection to Central and Eastern Europe.

BioeconomyFranceSwedenGermanyNetherlandsFinland

23.03.2015 A BASF-led consortium aims to decrease bio-based production costs using industrial biotechnology. The Horizon2020 funded consortium is the sixth project of the SPIRE Public Private Partnership and has a budget of €14m.

Stock MarketsFranceSwedenUKNorwayIreland

20.03.2015 There are no signs of inertia creeping into the European biotech industry this spring. A total of eight IPOs are set to go public by the end of the year’s first quarter.

FinancingUKEU

17.03.2015 Pharma giants GlaxoSmithKline (GSK) and Johnson & Johnson (J&J) will be key collaborators in a new global fund for dementia research to address the rising threat posed by dementia and Alzheimer’s disease.

FinancingFranceDenmarkSwedenGermany

19.03.2015 French venture capital firm Seventure Partners has raised a further €25m for its microbiome-focused Health for Life Capital Fund. It now stands at €100m.

EventsFranceEUSwitzerlandUKGermany

12.03.2015 With around 1,400 companies and 2,400 participants, the springtime counterpart of BIO-Europe enjoyed a successful premiere in France this year. The overall mood of the European biotech industry was positive, and the French hosts in particular reported new initiatives.

M&ABelgium

11.03.2015 Belgian cell-based therapeutics developer and CMO MaSTherCell SA has been acquired by US biotech Orgenesis Inc. for €23m.

FinancingGermany

10.03.2015 The Gates Foundation has dipped into its purse to bring infectious diseases vaccines to the poorest countries. German vaccine specialist CureVac is set to receive US$52m for their mRNA platform technology.

Stock MarketsIrelandUK

05.03.2015 The IPO wave in the biotech sector shows no signs of slowing down. An Irish life sciences fund set up by former Elan executives plans to raise €325m with its IPO, whilst Summit Therapeutics has announced its IPO pricing of US$34m on Nasdaq.

LicencingDenmark

05.03.2015 Bavarian Nordic is outlicensing its Phase 3 prostate cancer immunotherapy Prostvac to pharma heavyweight Bristol Myers Squibb for a tidy €881m.

Events

All Events

Current issue

All issues

Product of the week

Products

Stock list

All quotes

TOP

  • CYTOS1.54 CHF14.07%
  • SYNGENTA329.00 CHF0.27%
  • 4SC0.84 EUR0.00%

FLOP

  • THERAMETRICS0.07 CHF-12.50%
  • BASILEA110.00 CHF-2.65%
  • ACTELION114.70 CHF-1.88%

TOP

  • CYTOS1.54 CHF352.9%
  • MEDIGENE13.50 EUR217.6%
  • FORMYCON26.00 EUR55.7%

FLOP

  • WILEX2.92 EUR-14.9%
  • BASILEA110.00 CHF-10.0%
  • MORPHOSYS70.55 EUR-5.6%

TOP

  • SANTHERA95.40 CHF2346.2%
  • WILEX2.92 EUR386.7%
  • FORMYCON26.00 EUR273.6%

FLOP

  • CYTOS1.54 CHF-49.7%
  • 4SC0.84 EUR-37.3%
  • THERAMETRICS0.07 CHF-36.4%

No liability assumed, Date: 26.03.2015